GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.640
-0.065 (-3.81%)
Nov 16, 2026, 10:20 AM EST - Market open

GeoVax Labs Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-2.493.95-0.080.39
Revenue Growth
--37.06%---78.85%-78.86%
Cost of Revenue
18.1218.1223.7120.729.1215.55
Gross Profit
-18.12-15.63-19.76-20.72-9.04-15.17
Selling, General & Admin
5.56.015.396.024.993.58
Operating Expenses
0.216.015.396.024.993.58
Operating Income
-18.33-21.64-25.14-26.74-14.03-18.75
Interest Expense
---0.02---0
Interest & Investment Income
0.070.170.170.780.010
EBT Excluding Unusual Items
-18.26-21.46-24.99-25.97-14.02-18.74
Other Unusual Items
-----0.17
Pretax Income
-18.26-21.46-24.99-25.97-14.02-18.57
Net Income
-18.26-21.46-24.99-25.97-14.02-18.57
Net Income to Common
-18.26-21.46-24.99-25.97-14.02-18.57
Net Income Growth
------
Shares Outstanding (Basic)
00----
Shares Outstanding (Diluted)
00----
Shares Change
617.68%-----
EPS (Basic)
-98.30-537.49----
EPS (Diluted)
-98.30-537.49----
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-16.5-21.5-24.7-25.22-19.16-11.24
Free Cash Flow Per Share
-88.81-538.41----
Operating Margin
--869.34%-635.83%--17207.47%-4862.72%
Profit Margin
--862.34%-631.98%--17198.35%-4817.19%
Free Cash Flow Margin
--863.81%-624.50%--23507.18%-2916.76%
EBITDA
-18.28-21.57-25.05-26.67-13.97-18.71
D&A For EBITDA
0.050.070.10.070.060.04
EBIT
-18.33-21.64-25.14-26.74-14.03-18.75
SEC Filings: 10-K · 10-Q